RT Journal Article
SR Electronic
T1 On the parameterization of mathematical models of infectious disease transmission structured by age at the start of the epidemic spread
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.04.11.24305604
DO 10.1101/2024.04.11.24305604
A1 Sarratea, Santiago
A1 Fabricius, Gabriel
YR 2024
UL http://medrxiv.org/content/early/2024/04/12/2024.04.11.24305604.abstract
AB Estimation of transmission and contact rate parameters among individuals in different age groups is a key point in the mathematical modeling of infectious disease transmission. Several approaches exist for this task but, given the complexity of the problem, the obtained values are always approximate estimations that hold in particular conditions. Our goal is to contribute to this task in the event of an emerging disease. We propose a methodology to estimate the contact rate parameters from the fraction of the incidence reported in each age group at the beginning of the epidemic spread. Working with an age-structured SIR model, we obtain an equation that relates the contact parameters to various epidemiological quantities that could be accessible through different sources. We apply the method to obtain information about the contact structure by age during the COVID-19 epidemic spread in Greater Buenos Aires (Argentina) in 2020. As we have the fractions of reported incidence by age but only rough estimations of other quantities involved in the method, we define several epidemiological scenarios based on various hypotheses. Using the different sets of contact parameters obtained, we evaluate control strategies and analyze the dependence of the results on our assumptions. The proposed method could be useful to obtain a fast first insight of a new emergent disease at the beginning of epidemic spread using the accessible information.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis studied was funded by the Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET) through PIP 0292 (2017-2019) and PIP 0266 (2022-2024).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesData is available at: https://datos.gob.ar/dataset/salud-covid-19-casos-registrados-republica-argentina/archivo/salud fd657d02-a33a-498b-a91b-2ef1a68b8d16